CAR T-cells followed by CD34-selected T-cell depleted (TCD) ALLO-HSCT is associated with low toxicity and favorable overall survival Meeting Abstract


Authors: Fabrizio, V.; Boulad, F.; Cancio, M.; Margossian, S.; Mauguen, A.; Prockop, S.; Scaradavou, M.; Shah, N.; Spitzer, B.; Stieglitz, E.; Kernan, N.; O'Reilly, R.; Boelens, J. J.; Curran, K.
Abstract Title: CAR T-cells followed by CD34-selected T-cell depleted (TCD) ALLO-HSCT is associated with low toxicity and favorable overall survival
Meeting Title: 51st Congress of the International Society of Paediatric Oncology (SIOP)
Journal Title: Pediatric Blood and Cancer
Volume: 66
Issue: Suppl. 4
Meeting Dates: 2019 Oct 23-26
Meeting Location: Lyon, France
ISSN: 1545-5009
Publisher: Wiley Periodicals, Inc  
Date Published: 2019-12-01
Start Page: S43
Language: English
ACCESSION: WOS:000488458000077
PROVIDER: wos
PUBMED: 31568621
DOI: 10.1002/pbc.27989
Notes: Meeting Abstract: FP070 SIOP19-0455 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nancy Kernan
    512 Kernan
  2. Farid Boulad
    329 Boulad
  3. Susan E Prockop
    262 Prockop
  4. Kevin Joseph Curran
    144 Curran
  5. Richard O'Reilly
    747 O'Reilly
  6. Barbara Spitzer
    78 Spitzer
  7. Audrey   Mauguen
    155 Mauguen
  8. Maria   Cancio
    57 Cancio
  9. Jaap Jan Boelens
    204 Boelens